Siobhan Clerkin

Medawar Building for Pathogen Research

Papers

1

Total Citations

31

H-Index

1

About

Siobhan Clerkin has pioneered innovative approaches to antibody discovery, with a particular focus on targeting membrane proteins in their native conformations—a notoriously difficult challenge in biotechnology. Her most-cited work, a 2020 paper with 31 citations, introduces a novel mammalian display system that enables the selection of antibodies against membrane proteins in their natural cellular environment. This breakthrough addresses a critical bottleneck in the development of reliable, specific antibodies for both research and therapeutic applications. By circumventing the limitations of traditional methods that rely on purified or denatured antigens, Clerkin’s system allows for the identification of antibodies that recognize physiologically relevant epitopes. Her contributions have significant implications for drug development, diagnostics, and basic cell biology, where membrane proteins are frequent but elusive targets. Clerkin’s work exemplifies the integration of synthetic biology and protein engineering to solve real-world biomedical challenges, marking her as an emerging leader in the field of antibody engineering and mammalian display technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Development of a novel mammalian display system for selection of antibodies against membrane proteins
31 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Medawar Building for Pathogen Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago